Document is current
Any future updates will be listed below
-
Authors
Brown, Rebecca J.
Oral, Elif A.
Cochran, Elaine
Araújo-Vilar, David
Savage, David B.
Long, Alison
Fine, Gregory
Salinardi, Taylor
Gorden, Phillip
-
Funding
Funding for this research was provided by:
Aegerion Pharmaceuticals, Inc.
- License Information
-
More Information
Article History
Received: 9 November 2017
Accepted: 26 March 2018
First Online: 12 April 2018
Compliance with ethical standards
:
: E.A.O. has served as a consultant to Aegerion, Akcea, AstraZeneca, and Regeneron, received grants from Aegerion, Akcea, AstraZeneca, Gemphire, GIDynamics, and received non-material support from Aegerion and Boehringer Ingelheim. D.A.V. and D.B.S. have served as consultants to Aegerion Pharmaceuticals. A.L. and G.F. are employees of Aegerion Pharmaceuticals. T.S. is a former employee of Aegerion Pharmaceuticals. R.J.B., E.C., and P.G. declares that they have no conflict of interest.